The Genetics of Atypical Femur Fractures—a Systematic Review

Wei Zhou; Jeroen G.J. van Rooij; Peter R. Ebeling; Annemieke J.M.H. Verkerk; M. Carola Zillikens

doi:10.1007/s11914-021-00658-y

The Genetics of Atypical Femur Fractures—a Systematic Review

Wei Zhou
, Jeroen G.J. van Rooij
, Peter R. Ebeling
, Annemieke J.M.H. Verkerk
, M. Carola Zillikens^*

^*Corresponding author for this work

Erasmus University Rotterdam
Monash University

Research output: Contribution to journal › Review article › Academic › peer-review

26 Citations (Scopus)

70 Downloads (Pure)

Abstract

Purpose of Review: Atypical femur fractures (AFFs) are rare subtrochanteric or diaphyseal fractures regarded as side effects of bisphosphonates (BPs), possibly with a genetic background. Here, we summarize the most recent knowledge about genetics of AFFs. Recent Findings: AFF has been reported in 57 patients with seven different monogenic bone disorders including hypophosphatasia and osteogenesis imperfecta; 56.1% had never used BPs, while 17.5% were diagnosed with the disorder only after the AFF. Gene mutation finding in familial and sporadic cases identified possible AFF-related variants in the GGPS1 and ATRAID genes respectively. Functional follow-up studies of mutant proteins showed possible roles in AFF. A recent small genome-wide association study on 51 AFF cases did not identify significant hits associated with AFF. Summary: Recent findings have strengthened the hypothesis that AFFs have underlying genetic components but more studies are needed in AFF families and larger cohorts of sporadic cases to confirm previous results and/or find novel gene variants involved in the pathogenesis of AFFs.

Original language	English
Pages (from-to)	123-130
Number of pages	8
Journal	Current Osteoporosis Reports
Volume	19
Issue number	2
DOIs	https://doi.org/10.1007/s11914-021-00658-y
Publication status	Published - Apr 2021

Bibliographical note

Acknowledgements: The authors are grateful for the support from the
Jaap Schouten Foundation, Rotterdam, the Netherlands, and the
National Health and Medical Research Council of Australia. The authors
also wish to thank Maarten F.M. Engel from the Erasmus MC Medical
Library for developing and updating the search strategies.

Publisher Copyright: © 2021, The Author(s).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s11914-021-00658-y

Zhou2021_Article_TheGeneticsOfAtypicalFemurFracLicence: CC BY

Cite this

@article{6c956f55bd9541d485e337b2c35f1837,

title = "The Genetics of Atypical Femur Fractures{\textemdash}a Systematic Review",

abstract = "Purpose of Review: Atypical femur fractures (AFFs) are rare subtrochanteric or diaphyseal fractures regarded as side effects of bisphosphonates (BPs), possibly with a genetic background. Here, we summarize the most recent knowledge about genetics of AFFs. Recent Findings: AFF has been reported in 57 patients with seven different monogenic bone disorders including hypophosphatasia and osteogenesis imperfecta; 56.1\% had never used BPs, while 17.5\% were diagnosed with the disorder only after the AFF. Gene mutation finding in familial and sporadic cases identified possible AFF-related variants in the GGPS1 and ATRAID genes respectively. Functional follow-up studies of mutant proteins showed possible roles in AFF. A recent small genome-wide association study on 51 AFF cases did not identify significant hits associated with AFF. Summary: Recent findings have strengthened the hypothesis that AFFs have underlying genetic components but more studies are needed in AFF families and larger cohorts of sporadic cases to confirm previous results and/or find novel gene variants involved in the pathogenesis of AFFs.",

author = "Wei Zhou and \{van Rooij\}, \{Jeroen G.J.\} and Ebeling, \{Peter R.\} and Verkerk, \{Annemieke J.M.H.\} and Zillikens, \{M. Carola\}",

note = "Acknowledgements: The authors are grateful for the support from the Jaap Schouten Foundation, Rotterdam, the Netherlands, and the National Health and Medical Research Council of Australia. The authors also wish to thank Maarten F.M. Engel from the Erasmus MC Medical Library for developing and updating the search strategies. Publisher Copyright: {\textcopyright} 2021, The Author(s).",

year = "2021",

month = apr,

doi = "10.1007/s11914-021-00658-y",

language = "English",

volume = "19",

pages = "123--130",

journal = "Current Osteoporosis Reports",

issn = "1544-1873",

publisher = "Springer",

number = "2",

}

TY - JOUR

T1 - The Genetics of Atypical Femur Fractures—a Systematic Review

AU - Zhou, Wei

AU - van Rooij, Jeroen G.J.

AU - Ebeling, Peter R.

AU - Verkerk, Annemieke J.M.H.

AU - Zillikens, M. Carola

N1 - Acknowledgements: The authors are grateful for the support from the Jaap Schouten Foundation, Rotterdam, the Netherlands, and the National Health and Medical Research Council of Australia. The authors also wish to thank Maarten F.M. Engel from the Erasmus MC Medical Library for developing and updating the search strategies. Publisher Copyright: © 2021, The Author(s).

PY - 2021/4

Y1 - 2021/4

N2 - Purpose of Review: Atypical femur fractures (AFFs) are rare subtrochanteric or diaphyseal fractures regarded as side effects of bisphosphonates (BPs), possibly with a genetic background. Here, we summarize the most recent knowledge about genetics of AFFs. Recent Findings: AFF has been reported in 57 patients with seven different monogenic bone disorders including hypophosphatasia and osteogenesis imperfecta; 56.1% had never used BPs, while 17.5% were diagnosed with the disorder only after the AFF. Gene mutation finding in familial and sporadic cases identified possible AFF-related variants in the GGPS1 and ATRAID genes respectively. Functional follow-up studies of mutant proteins showed possible roles in AFF. A recent small genome-wide association study on 51 AFF cases did not identify significant hits associated with AFF. Summary: Recent findings have strengthened the hypothesis that AFFs have underlying genetic components but more studies are needed in AFF families and larger cohorts of sporadic cases to confirm previous results and/or find novel gene variants involved in the pathogenesis of AFFs.

AB - Purpose of Review: Atypical femur fractures (AFFs) are rare subtrochanteric or diaphyseal fractures regarded as side effects of bisphosphonates (BPs), possibly with a genetic background. Here, we summarize the most recent knowledge about genetics of AFFs. Recent Findings: AFF has been reported in 57 patients with seven different monogenic bone disorders including hypophosphatasia and osteogenesis imperfecta; 56.1% had never used BPs, while 17.5% were diagnosed with the disorder only after the AFF. Gene mutation finding in familial and sporadic cases identified possible AFF-related variants in the GGPS1 and ATRAID genes respectively. Functional follow-up studies of mutant proteins showed possible roles in AFF. A recent small genome-wide association study on 51 AFF cases did not identify significant hits associated with AFF. Summary: Recent findings have strengthened the hypothesis that AFFs have underlying genetic components but more studies are needed in AFF families and larger cohorts of sporadic cases to confirm previous results and/or find novel gene variants involved in the pathogenesis of AFFs.

UR - https://www.scopus.com/pages/publications/85101447315

U2 - 10.1007/s11914-021-00658-y

DO - 10.1007/s11914-021-00658-y

M3 - Review article

C2 - 33587247

AN - SCOPUS:85101447315

SN - 1544-1873

VL - 19

SP - 123

EP - 130

JO - Current Osteoporosis Reports

JF - Current Osteoporosis Reports

IS - 2

ER -

The Genetics of Atypical Femur Fractures—a Systematic Review

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this